S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

RPTX Repare Therapeutics Inc

1.28

0.01 (0.79%)

Pre Market

Last Updated: 04:33:19

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Repare Therapeutics (NASDAQ:RPTX)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Repare Therapeutics Charts.

Repare Therapeutics (NASDAQ:RPTX)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Repare Therapeutics Charts.

Repare Therapeutics Inc News

Form 8-K - Current report
Friday 10 January 2025 (5 days ago) • Edgar (US Regulatory)

Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions
Thursday 9 January 2025 (6 days ago) • Business Wire

Form 8-K - Current report
Thursday 12 December 2024 (1 month ago) • Edgar (US Regulatory)

Repare Therapeutics Announces Positive Results of the Lunresertib and Camonsertib Combination from the MYTHIC Phase 1 Gynecologic Expansion Clinical Trial
Thursday 12 December 2024 (1 month ago) • Business Wire

Repare Therapeutics to Host Webcast to Report Data from the Lunresertib and Camonsertib Combination Phase 1 MYTHIC Clinical Trial
Tuesday 10 December 2024 (1 month ago) • Business Wire

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib
Tuesday 12 November 2024 (2 months ago) • Business Wire

Form 424B5 - Prospectus [Rule 424(b)(5)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results
Thursday 7 November 2024 (2 months ago) • Business Wire

More Repare Therapeutics Inc News Articles

Vontobel Financial Produ...

Madison Pacific Properties

Goldman Sachs Finance

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions